Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

FoxO transcription factors; Regulation by AKT and 14-3-3 proteins.

Tzivion G, Dobson M, Ramakrishnan G.

Biochim Biophys Acta. 2011 Nov;1813(11):1938-45. doi: 10.1016/j.bbamcr.2011.06.002. Review.

2.

Regulation of FoxO transcription factors by acetylation and protein-protein interactions.

Daitoku H, Sakamaki J, Fukamizu A.

Biochim Biophys Acta. 2011 Nov;1813(11):1954-60. doi: 10.1016/j.bbamcr.2011.03.001. Review.

3.

Regulation of FOXO protein stability via ubiquitination and proteasome degradation.

Huang H, Tindall DJ.

Biochim Biophys Acta. 2011 Nov;1813(11):1961-4. doi: 10.1016/j.bbamcr.2011.01.007. Review.

4.

Akt, FoxO and regulation of apoptosis.

Zhang X, Tang N, Hadden TJ, Rishi AK.

Biochim Biophys Acta. 2011 Nov;1813(11):1978-86. doi: 10.1016/j.bbamcr.2011.03.010. Review.

5.

CNK1 and other scaffolds for Akt/FoxO signaling.

Fritz RD, Radziwill G.

Biochim Biophys Acta. 2011 Nov;1813(11):1971-7. doi: 10.1016/j.bbamcr.2011.02.008. Review.

6.

FoxO family members in cancer.

Zhang Y, Gan B, Liu D, Paik JH.

Cancer Biol Ther. 2011 Aug 15;12(4):253-9. Review.

PMID:
21613825
7.

Interplay between FOXO, TOR, and Akt.

Hay N.

Biochim Biophys Acta. 2011 Nov;1813(11):1965-70. doi: 10.1016/j.bbamcr.2011.03.013. Review.

8.

The PKB/FOXO switch in aging and cancer.

Kloet DE, Burgering BM.

Biochim Biophys Acta. 2011 Nov;1813(11):1926-37. doi: 10.1016/j.bbamcr.2011.04.003. Review.

9.

Structural basis for DNA recognition by FOXO proteins.

Obsil T, Obsilova V.

Biochim Biophys Acta. 2011 Nov;1813(11):1946-53. doi: 10.1016/j.bbamcr.2010.11.025. Review.

10.

The "O" class: crafting clinical care with FoxO transcription factors.

Maiese K, Chong ZZ, Hou J, Shang YC.

Adv Exp Med Biol. 2009;665:242-60. Review.

11.

Redox regulation of FoxO transcription factors.

Klotz LO, Sánchez-Ramos C, Prieto-Arroyo I, Urbánek P, Steinbrenner H, Monsalve M.

Redox Biol. 2015 Dec;6:51-72. doi: 10.1016/j.redox.2015.06.019. Review.

12.

OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.

Maiese K, Chong ZZ, Shang YC.

Trends Mol Med. 2008 May;14(5):219-27. doi: 10.1016/j.molmed.2008.03.002. Review.

13.

Should I stay or should I go: beta-catenin decides under stress.

Hoogeboom D, Burgering BM.

Biochim Biophys Acta. 2009 Dec;1796(2):63-74. doi: 10.1016/j.bbcan.2009.02.002. Review.

PMID:
19268509
14.

Forkhead box class O transcription factors in liver function and disease.

Tikhanovich I, Cox J, Weinman SA.

J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:125-31. doi: 10.1111/jgh.12021. Review.

15.

Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty.

Burgering BM, Medema RH.

J Leukoc Biol. 2003 Jun;73(6):689-701. Review.

PMID:
12773501
16.

Lymphocyte signaling: regulation of FoxO transcription factors by microRNAs.

Haftmann C, Stittrich AB, Sgouroudis E, Matz M, Chang HD, Radbruch A, Mashreghi MF.

Ann N Y Acad Sci. 2012 Jan;1247:46-55. doi: 10.1111/j.1749-6632.2011.06264.x. Review.

PMID:
22236474
17.

Long live FOXO: unraveling the role of FOXO proteins in aging and longevity.

Martins R, Lithgow GJ, Link W.

Aging Cell. 2016 Apr;15(2):196-207. doi: 10.1111/acel.12427. Review.

18.

Many forks in the path: cycling with FoxO.

Ho KK, Myatt SS, Lam EW.

Oncogene. 2008 Apr 7;27(16):2300-11. doi: 10.1038/onc.2008.23. Review.

PMID:
18391972
19.

Multiple modes of chromatin remodeling by Forkhead box proteins.

Lalmansingh AS, Karmakar S, Jin Y, Nagaich AK.

Biochim Biophys Acta. 2012 Jul;1819(7):707-15. doi: 10.1016/j.bbagrm.2012.02.018. Review.

PMID:
22406422
20.

Fox transcription factors: from development to disease.

Golson ML, Kaestner KH.

Development. 2016 Dec 15;143(24):4558-4570. Review.

PMID:
27965437
Items per page

Supplemental Content

Support Center